Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database

BACKGROUND: Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). AIMS: To evaluate real-world data in US patients with UC receiving tofacitinib. METHODS: Characteristics and outcomes of patients with UC initiating tofacitinib between 2018 and 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiorean, Michael, Ha, Christina, Hur, Peter, Sharma, Puza P., Gruben, David, Khan, Nabeel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516786/
https://www.ncbi.nlm.nih.gov/pubmed/37639057
http://dx.doi.org/10.1007/s10620-023-08063-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516786/
https://www.ncbi.nlm.nih.gov/pubmed/37639057
http://dx.doi.org/10.1007/s10620-023-08063-4

Ejemplares similares